Asthma and CRSwNP Care: Separating the Breathing Truths from the Myths

Rethinking Asthma and CRSwNP Care

For decades, asthma and chronic rhinosinusitis with nasal polyps (CRSwNP) have been treated as separate conditions — managed independently by pulmonologists, ENT specialists, and allergologists. But emerging science is transforming the way we understand airway disease.

With innovative treatments now targeting inflammation across both the upper and lower airways, a more integrated approach to care is becoming essential.

In this edition of EUFOREA News, Dr. Marjolein Cornet (The Netherlands) and Professor Enrico Heffler (Italy) explore the latest developments in asthma and CRSwNP management — challenging common misconceptions and sharing expert insights into modern, patient-centred care.

Join us as we separate myth from reality and discuss how collaboration across specialties can help improve outcomes for patients living with chronic airway diseases.

Please note: The discussion reflects the independent clinical experience and views of the faculty. Treatment decisions should always be based on local prescribing information.

This EUFOREA News programme was supported through an unrestricted educational grant from GSK.